← Leaderboards
Sabrina Alves Simoes Spassov
Columbia University Health Sciences
$3,109,918
Attributed
$3,109,918
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $962.9K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,109,918 · 4
By mechanism
R01$1,825,240 · 1
R21$897,875 · 2
P01$386,803 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Richard Mayeux$113,943,785
- Ira A Tabas$44,847,082
- Estela Area Gomez$2,921,928
- Diane Berengere Re$7,904,391
- Christiane Reitz$17,861,730
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseBiological MarkersTau ProteinsTraffickingLinkFunctional DisorderGeneticProteomicsS Disease PatientMouse ModelAplp1 GeneDesignWestern BlottingNeuronsPlasmaAmyloid Beta-ProteinEndosomesAlzheimerâS Disease BiomarkerProteinsTechnologyCognitiveCerebrospinal FluidCellular Biology
Grant awards (8)
Targeting Endosomal dysfunction as a new source of biomarkers for Alzheimer's disease$401,007
R01 · FY2025 · AG · contact PI
SORL1 and its involvement in Alzheimer's disease pathogenesis and pathophysiology - Project 4$386,803
P01 · FY2025 · AG · contact PI
Targeting Endosomal dysfunction as a new source of biomarkers for Alzheimer's disease$405,734
R01 · FY2024 · AG · contact PI
Targeting Endosomal dysfunction as a new source of biomarkers for Alzheimer's disease$510,521
R01 · FY2023 · AG · contact PI
Investigate the utility of APLP1 as an endosomal biomarker for Alzheimer's Disease in Down Syndrome$452,375
R21 · FY2023 · AG · contact PI
Targeting Endosomal dysfunction as a new source of biomarkers for Alzheimer's disease$507,978
R01 · FY2022 · AG · contact PI
Endosomal dysfunction, a new source of biomarkers for Alzheimer's disease.$202,500
R21 · FY2022 · AG · contact PI
Endosomal dysfunction, a new source of biomarkers for Alzheimer's disease.$243,000
R21 · FY2021 · AG · contact PI